Covered recipient · General Payments record
TIMOTHY F SIMPSON
Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology
General Payments · PY2021–2024
$11,903.37
- Reported across 131 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $942.90 | 3 |
| Food and Beverage | $670.17 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $1,116.33 | 6 |
| ABIOMED | $286.02 | 11 |
| BOSTON SCIENTIFIC CORPORATION | $53.33 | 2 |
| E.R. Squibb & Sons, L.L.C. | $49.60 | 2 |
| ShockWave Medical, Inc | $38.67 | 2 |
| CVRx Inc. | $24.97 | 1 |
| Acerta Pharma LLC | $23.08 | 1 |
| Novo Nordisk AS | $21.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $322.60 | 05/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125407209 | CMS |
| Abbott Laboratories | $611.28 | 05/31/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125407207 | CMS |
| Abbott Laboratories | $9.02 | 05/31/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125407211 | CMS |
| Abbott Laboratories | $132.31 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125043484 | CMS |
| Abbott Laboratories | $22.52 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125043486 | CMS |
| Abbott Laboratories | $18.60 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125043488 | CMS |
| ABIOMED | $29.67 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259000 | CMS |
| ABIOMED | $56.80 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259010 | CMS |
| ABIOMED | $38.33 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259022 | CMS |
| ABIOMED | $8.13 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259024 | CMS |
| ABIOMED | $25.20 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259046 | CMS |
| ABIOMED | $74.82 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259042 | CMS |
| ABIOMED | $13.80 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258994 | CMS |
| ABIOMED | $31.40 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259144 | CMS |
| ABIOMED | $3.52 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259146 | CMS |
| ABIOMED | $2.75 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259166 | CMS |
| ABIOMED | $1.60 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142259168 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.08 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105401603 | CMS |
| Boston Scientific Corporation | $16.86 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092751828 | CMS |
| Boston Scientific Corporation | $36.47 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092751830 | CMS |
| CVRx, Inc. | $24.97 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138614917 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.22 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101275907 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.38 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101275909 | CMS |
| Novo Nordisk Inc | $21.07 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097072722 | CMS |
| ShockWave Medical, Inc | $17.25 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152994285 | CMS |
| ShockWave Medical, Inc | $21.42 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152971273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.